"Sborz, 32, returns to the team he has spent the past five years with. The highlight of that tenure was 2023. Sborz had an unimpressive 5.50 earned run average that season but the underlying marks were better. His 7.9% walk rate was a bit better than average and his 30.7% strikeout rate was very strong. A small 56% strand rate seemed to push some extra runs across, which is why his 3.75 FIP and 3.05 SIERA were much more optimistic."
"Sborz gave the Rangers 12 innings over 10 appearances, only allowing one earned run while striking out 13, making him one of most impactful players in the club's championship. Things have been a bit more rocky since then, however. Rotator cuff/shoulder issues hampered him throughout 2024 and he only pitched 16 1/3 innings that season. He underwent a debridement surgery in November of that year, a procedure that was expected to sideline him for the first two or three months of the 2025 campaign."
Josh Sborz, 32, rejoined the Rangers on a minor league contract with an invite to big-league spring training. He spent the past five seasons with the club and produced strong underlying numbers in 2023 despite a 5.50 ERA, posting a 7.9% walk rate, 30.7% strikeout rate, 3.75 FIP and 3.05 SIERA. He yielded 12 postseason innings across 10 appearances with one earned run and 13 strikeouts. Rotator cuff/shoulder problems limited him to 16 1/3 innings in 2024, leading to debridement surgery in November and a missed 2025 season while rehabbing. Texas non-tendered him but signed him to a low-risk non-roster deal to assess recovery and velocity.
Read at MLB Trade Rumors
Unable to calculate read time
Collection
[
|
...
]